FIGURE 1.
(A) Morphological analysis of the cells using an inverted microscope (×100). (B) MTT assay results in 24 h after CAP application. CAP selectively diminished the viability of B16 melanoma cancer cells in a dose‐response manner, while it not affected on the viability of normal L929 cells. The tests were performed three times.